Skip to search formSkip to main contentSkip to account menu

fowlpox-CEA-TRICOM vaccine

Known as: Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine, fowlpox-CEA-B7.1/ICAM-1/LFA-3, fCEA-TRI 
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Results: 82 pretreated mCRC pts were enrolled (ITT); including 32 (39%) previously treated with FOLFIRIþ/ bev. Of the 82 pts… 
2015
2015
To investigate the feasibility of applying PTD-modified ATTEMPTS (Antibody Targeted Triggered Electrically Modified Prodrug-Type… 
2007
2007
Systemic IL-2 is currently employed in the therapy of several tumor types, but at the price of often severe toxicities. Local… 
Review
2004
Review
2004
Colorectal cancer is one of the leading causes of cancer-related mortality. After a series of clinical trials, the adjuvant 5-FU… 
2004
2004
BACKGROUND & OBJECTIVE Carcinoembryonic antigen (CEA) positive cancers are poorly responded to different kinds of treatments… 
2004
2004
Objective To construt highly expression of HBD2 system in eucaryotic cell. Methods To construct recombinant retrovirus expression… 
2003
2003
BACKGROUND The costimulatory molecules B7-1, intercellular adhesion molecule-1 (ICAM-1), and leukocyte function-associated… 
2001
2001
Les proprietes de coherence ainsi que la tres courte duree des impulsions de la generation d'harmonique d'ordre eleve ont ete… 
2001
2001
Objective: To evaluate the significance of including CEA in serum and tissues in the management protocol of patients with ovarian… 
1988
1988